DailyDoctor Archive Specialties Get app
Back to the 15 September 2026 edition

Regulatory · 02 of 05

Class II recall of premixed intravenous pantoprazole

Check premixed intravenous pantoprazole stock against the recall, and if you are back to preparing from vials, write the full regimen at the bedside.

The FDA sweep carries an ongoing Class II recall of pantoprazole sodium in sodium chloride, 80 mg in 100 mL, supplied as a single-dose infusion bag, for deviations from current good manufacturing practice. Class II means use may cause temporary or medically reversible harm, with serious harm unlikely.

This is a supply problem, not a finding about pantoprazole. It matters because of where the premixed bag sits in practice: the high-dose intravenous proton pump inhibitor infusion after endoscopic haemostasis for a bleeding ulcer, started at speed, often out of hours, by staff who have the protocol but not the arithmetic to hand. Take the premix away and both the bolus and the infusion rate have to be constructed from vials.

Check stock against the notice. If you are reverting to reconstitution, write the regimen where it will be prepared - bolus dose, infusion concentration, rate and duration - and confirm with pharmacy which presentation is arriving. Nothing about the indication or the dose changes.

  • Check endoscopy unit, ward and pharmacy stock against the current recall notice.
  • If reverting to vials, post the full high-dose regimen - bolus, concentration, rate, duration - at the preparation point.
  • Confirm the substitute presentation's strength explicitly rather than assuming it matches.
  • Brief the on-call and night teams, who are most likely to need the infusion first.
  • The evidence for high-dose intravenous proton pump inhibitor after endoscopic haemostasis is unchanged.

Why it matters

The drug is most needed in the middle of a gastrointestinal bleed, which is the worst moment to be reconstructing a regimen from first principles.

Don't overread it

A Class II recall for manufacturing deviations is a supply action, not evidence of harm from pantoprazole.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

ibd

Tomorrow morning, before your first patient

One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app